NEPHROS INC
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 5, 2026 (10 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 8, 2025 | Maxim Group | maintain | Buy → Buy | $6 | 42% |
| Nov 12, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $5 | 54% |
| May 15, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $5 | 54% |
| Mar 8, 2024 | Benchmark | upgrade | Hold → Speculative Buy | $5 | 54% |
| Jan 26, 2021 | B. Riley Securities | initiate | — → Buy | $12.5 | 54% |
| Oct 24, 2019 | Benchmark | initiate | — → Speculative Buy | $16 | 54% |
| Oct 4, 2019 | Maxim Group | initiate | — → Buy | $0 | 42% |
No cross-platform signals in the last 90 days